1 week Ago By ABMN Staff
StockNews.com upgraded shares of Pro-Dex ( NASDAQ:PDEX – Free Report ) from a buy rating to a strong-buy rating in a report published on Saturday morning. Pro-Dex Price Performance Pro-Dex stock opened at $23.
28 on Friday. The company has a debt-to-equity ratio of 0.25, a current ratio of 3.
45 and a quick ratio of 2.08. The stock has a market cap of $79.
59 million, a price-to-earnings ratio of 40.14 and a beta of 0.38.
The firm has a 50-day moving average of $19.73 and a two-hundred day moving average of $18.86.
Pro-Dex has a 1 year low of $14.51 and a 1 year high of $24.74.
Pro-Dex ( NASDAQ:PDEX – Get Free Report ) last announced its quarterly earnings results on Thursday, September 5th. The medical instruments supplier reported $0.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.
35 by $0.11. The firm had revenue of $15.
03 million during the quarter. Pro-Dex had a return on equity of 6.50% and a net margin of 4.
13%. Insider Activity Hedge Funds Weigh In On Pro-Dex Large investors have recently bought and sold shares of the business. Dimensional Fund Advisors LP boosted its position in Pro-Dex by 5.
1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 63,036 shares of the medical instruments supplier’s stock valued at $1,238,000 after acquiring an additional 3,067 shares in the last quarter. Perritt Capital Management Inc.
grew its stake in Pro-Dex by 43.3% in the first quarter. Perritt Capital Management Inc.
now owns 6,000 shares of the medical instruments supplier’s stock valued at $106,000 after purchasing an additional 1,813 shares during the last quarter. Finally, Renaissance Technologies LLC raised its holdings in Pro-Dex by 7.9% in the second quarter.
Renaissance Technologies LLC now owns 12,240 shares of the medical instruments supplier’s stock worth $240,000 after purchasing an additional 900 shares in the last quarter. Institutional investors own 15.28% of the company’s stock.
Pro-Dex Company Profile ( Get Free Report ) Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. See Also Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.
com's FREE daily email newsletter ..
